RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
Ego Seeman(The University of Melbourne), R. Rizzoli, Lianne Tile, T. Thomas, J. Reeve(Nuffield Orthopaedic Centre), Lynn Darbie, Dieter Felsenberg(Charité - Universitätsmedizin Berlin), G D'Alò, Albert T. Cheung(University of Pennsylvania), B. Borah, E.L. Morris, Oliver Bock, Michel Laroche(Hôpital Rangueil), R. Chapurlat, José Zanchetta(Universidad del Salvador)
Oxford University Research Archive (ORA) (University of Oxford)
January 1, 2010
Cited by 4
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k